Recognizing peptic ulcer disease: Keys to clinical and laboratory diagnosis

Postgraduate Medicine

Volumn 105, Issue 3, 1999, Pages 113-133

  Graham, David Y ^a   Rakel, Robert E ^a   Fendrick, A Mark ^a   Go, Mae F ^a   Marshall, Barry J ^a   Peura, David A ^a   Scherger, Joseph E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STOMACH SECRETION INHIBITOR;

ALGORITHM; ANTIBIOTIC THERAPY; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; HUMAN; LABORATORY TEST; PATIENT SELECTION; PEPTIC ULCER; TREATMENT PLANNING;

EID: 0032900394     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1999.03.594     Document Type: Conference Paper

References (31)

1. Peterson WL, Graham DY. Helicobacter pylori. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 6th ed. Philadelphia: Saunders, 1998:604-19
2. Fendrick AM, Hirth RA, Chernew ME. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. Am J Gastroenterol 1996;91(8):1544-8
3. Fendrick AM, Chernew ME, Hirth RA, et al. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995;123(4):260-8
4. Abraham P, Bhatia SJ. Position paper on Helicobacter pylori in India. Indian Society of Gastroenterology. Indian J Gastroenterol 1997;16(Suppl 1):S29-33
5. Graham DY. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand. Am J Gastroenterol 1996;91(10): 2080-6
6. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1985;28(6):686-92
7. Gabriel SE, Bombardier C. NSAID induced ulcers: an emerging epidemic? J Rheumatol 1990;17(1):1-4
8. Fries JF. Assessing and understanding patient risk. Scand J Rheumatol 1992;92(Suppl):21-4
9. Fries JF, Williams CA, Bloch DA, et al. Nonsteroidal antiinflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991;91(3):213-22
10. Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 1991; 28(Suppl):6-10
11. Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998;338(11):719-26
12. Graham DY. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology 1989;96(2 Pt 2 Suppl):675-81
13. Agrawal NM, Roth S, Graham DY, et al. Misoprostol compared with sucralfate in the prevention of nonsteroidal antiinflammatory drug-induced gastric ulcer: a randomized, controlled trial. Ann Intern Med 1991;115(3):195-200
14. Graham DY, White RH, Moreland LW, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs: Misoprostol Study Group. Ann Intern Med 1993;119(4): 257-62
15. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123(4):241-9
16. Agrawal NM. Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract. Br J Rheumatol 1995;34(Suppl 1):5-10
17. Raskin JB, White RH, Jackson JE, et al. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens. Ann Intern Med 1995;123(5):344-50
18. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs: Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Stugy Group. N Engl J Med 1998;338(11):727-34
19. Kahrilas PJ. Gastroesophageal reflux disease and its complication. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 6th ed. Philadelphia: Saunders, 1998:498-518
20. Cutler AF. Testing for Helicobacter pylori in clinical practice. Am J Med 1996;100(5A):35-39S; discussion 39-41S
21. 11C urea breath test. Am J Gastroenterol 1996;91(4):690-4
22. El-Zimaity HM, Segura AM, Genta RM, et al. Histologic assessment of Helicobacter pylori status after therapy: comparison of Giemsa, Diff-Quik, and Genta stains. Mod Pathol 1998;11(3):288-91
23. El-Zimaity HM, al-Assi MT, Genta RM, et al. Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test. Am J Gastroenterol 1995;90(11): 1962-4
24. El-Zimaity HM, Ota H, Scott S, et al. A new triple stain for Helicobacter pylori suitable for the autostainer: carbol fuchsin/Alcian blue/hematoxylin-eosin. Arch Pathol Lab Med 1998;122(8):732-6
25. Genta RM, Robason GO, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol 1994;25(3):221-6
26. Yousfi MM, El-Zimaity HM, Genta RM, et al. Evaluation of a new reagent strip rapid urease test for detection of Helicobacter pylori infection. Gastrointest Endosc 1996;44(5):519-22
27. Yousfi MM, El-Zimaity HM, Cole RA, et al. Detection of Helicobacter pylori by rapid urease tests: is biopsy size a critical variable? Gastrointest Endosc 1996;43(3):222-4
28. Graham DY. Can therapy even be denied for Helicobacter pylori infection? Gastroenterology 1997;113(6 Suppl):S113-7
29. Greenberg PD, Koch J, Cello JP. Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers. Am J Gastroenterol 1996;91(2):228-32
30. Rabeneck L, Graham DY. Helicobacter pylori: when to test, when to treat. Ann Intern Med 1997;126(4):315-6
31. Graham DY, Rabeneck L. Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol 1996;91(2): 188-90